Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Macdougall

Showing results (281-290 of 293) with videos related to

Pageof 30
Sort By:
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
The New England Journal of Medicine|November 5, 2021
Daprodustat for the Treatment of Anemia in Patients Undergoing DialysisAjay K Singh, Kevin Carroll, Vlado Perkovic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2021
The ASCEND-ND trial: study design and participant characteristicsVlado Perkovic, Allison Blackorby, Borut Cizman, et al.
The New England Journal of Medicine|November 5, 2021
Daprodustat for the Treatment of Anemia in Patients Not Undergoing DialysisAjay K Singh, Kevin Carroll, John J V McMurray, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonistsJohn A Lowe, Shari L DeNinno, Jotham W Coe, et al.
JAMA Internal Medicine|April 4, 2022
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical TrialAjay K Singh, Borut Cizman, Kevin Carroll, et al.
BMC Nephrology|July 27, 2022
The effect of intravenous iron supplementation on exercise capacity in iron-deficient but not anaemic patients with chronic kidney disease: study design and baseline data for a multicentre prospective double-blind randomised controlled trialSharlene A Greenwood, Nicholas Beckley-Hoelscher, Elham Asgari, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
Kidney International Reports|August 7, 2023
A Randomized Trial of Intravenous Iron Supplementation and Exercise on Exercise Capacity in Iron-Deficient Nonanemic Patients With CKDSharlene A Greenwood, Benjamin A Oliveira, Elham Asgari, et al.
Journal of Nephrology|March 13, 2021
Nomenclature in nephrology: preserving 'renal' and 'nephro' in the glossary of kidney health and diseaseKamyar Kalantar-Zadeh, Peter A McCullough, Sanjay Kumar Agarwal, et al.
Pageof 30

Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
The New England Journal of Medicine|November 5, 2021
Daprodustat for the Treatment of Anemia in Patients Undergoing DialysisAjay K Singh, Kevin Carroll, Vlado Perkovic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2021
The ASCEND-ND trial: study design and participant characteristicsVlado Perkovic, Allison Blackorby, Borut Cizman, et al.
The New England Journal of Medicine|November 5, 2021
Daprodustat for the Treatment of Anemia in Patients Not Undergoing DialysisAjay K Singh, Kevin Carroll, John J V McMurray, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonistsJohn A Lowe, Shari L DeNinno, Jotham W Coe, et al.
JAMA Internal Medicine|April 4, 2022
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical TrialAjay K Singh, Borut Cizman, Kevin Carroll, et al.
BMC Nephrology|July 27, 2022
The effect of intravenous iron supplementation on exercise capacity in iron-deficient but not anaemic patients with chronic kidney disease: study design and baseline data for a multicentre prospective double-blind randomised controlled trialSharlene A Greenwood, Nicholas Beckley-Hoelscher, Elham Asgari, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
Kidney International Reports|August 7, 2023
A Randomized Trial of Intravenous Iron Supplementation and Exercise on Exercise Capacity in Iron-Deficient Nonanemic Patients With CKDSharlene A Greenwood, Benjamin A Oliveira, Elham Asgari, et al.
Journal of Nephrology|March 13, 2021
Nomenclature in nephrology: preserving 'renal' and 'nephro' in the glossary of kidney health and diseaseKamyar Kalantar-Zadeh, Peter A McCullough, Sanjay Kumar Agarwal, et al.
Pageof 30